Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 278-145-6 | CAS number: 75234-41-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012-10-09 until 2013-01-03
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: according to OECD 476
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Principles of method if other than guideline:
- first experiment 4 hours treatment with and without metabolic activation
second experiment 24 hours treatment without metabolic activation, 4 hours treatment with metabolic activation - GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- HPRT
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: MEM
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Periodically "cleansed" against high spontaneous background: yes - Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital/Beta-Naphtoflavone induced Rat liver S9
- Test concentrations with justification for top dose:
- Experiment I:
without metabolic activation (4 h treatment): 175; 350; 700; 1400; 2100; 2800 µg/mL
with metabolic activation (4 h treatment): 350; 700; 1400; 2800; 4200; 5600 µg/mL
Experiment II:
without metabolic activation (24 h treatment): 87.5; 175; 350; 700; 1400; 2100 µg/mL
with metabolic activation (4 h treatment): 350; 700; 1400; 2800; 4200; 5600 µg/mL
In both experiments with and without metabolic activation the lowest concentration was not continued as a minimum of only four analysable concentrations is required. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: deionised water
- Justification for choice of solvent/vehicle: solubility properties - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: Experiment I: 4 hours with and without metabolic activation, Experiment II: 24 hours without metabolic activation, 4 hours with metabolic activation
- Expression time (cells in growth medium): 72 hours
- Selection time (if incubation with a selection agent): 10 days
SELECTION AGENT (mutation assays): 6-Thioguanine
NUMBER OF REPLICATIONS: 2
NUMBER OF CELLS EVALUATED: >1,5x10exp. 6
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency - Evaluation criteria:
- A test item producing neither a concentration-related increase of the mutant frequency nor a reproducible positive response at any of the test points is considered to be non-mutagenic in this system.
A mutagenic response is described as follows:
The test item is classified as mutagenic if it induces reproducibly with one of the concen¬trations a mutation frequency that is three times higher than the spontaneous mutation fre¬quency in the experiment.
The test item is classified as mutagenic if there is a reproducible concentration-related increase of the mutation frequency. Such evaluation may be considered also in the case that a threefold increase of the mutant frequency is not observed.
In a case by case evaluation this decision depends on the level of the correspon¬ding solvent control data. - Statistics:
- A linear regression (least squares) was performed to assess a possible dose dependent increase of mutant frequencies using SYSTAT(R)11 (SYSTAT Software, Inc., 501, Canal Boulevard, Suite C, Richmond, CA 94804, USA) statistics software. The number of mutant colonies obtained for the groups treated with the test item was compared to the solvent control groups. A trend is judged as significant whenever the p-value (probability value) is below 0.05. However, both, biological relevance and statistical significance were considered together.
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: Not effected (pH 7.33 in the solvent control versus pH 7.36 measured at 5600 µg/mL, pre-experiment)
- Effects of osmolality: No relevant increase (mOsm 269 in the solvent control versus 301 measured at 5600 µg/mL, pre-experiment)
- Evaporation from medium: Not examined
- Water solubility: --
- Precipitation: Pre-experiment: The test medium was checked for precipitation or phase separation at the end of each treatment period (4 or 24 hours) prior to removal of the test item. No precipitation or phase separation occurred up to the maximum concentration with and without metabolic activa-tion after 4 and 24 hours treatment.
Main experiments: No precipitation observed
- Other confounding effects: None
RANGE-FINDING/SCREENING STUDIES:
According to the current OECD Guideline for Cell Gene Mutation Tests at least four ana-lysable concentrations should be used in two parallel cultures. For freely-soluble and non-cytotoxic test items the maximum concentration should be 5 mg/mL, 5 µL/mL or 10 mM, whichever is the lowest. For cytotoxic test items the maximum concentration should result in approximately 10 to 20% relative survival or cell density at subcultivation and the ana-lysed concentrations should cover a range from the maximum to little or no cytotoxicity. Relatively insoluble test items should be tested up to the highest concentration that can be formulated in an appropriate solvent as solution or homogenous suspension. These test items should be tested up or beyond their limit of solubility. Precipitation should be evalu-ated at the end of treatment by the unaided eye.
The highest test item concentration used in the pre-test was 5600 µg/mL equal to ap-proximately 5000 µg/mL of the pure substance. The test item was dissolved in deionised water. Test item concentrations between 43.8 µg/mL and 5600 µg/mL were used to evalu-ate toxicity in the presence (4 hours treatment) and absence (4 hours and 24 hours treat-ment) of metabolic activation. Relevant cytotoxic effects indicated by a relative suspension growth below 50% were observed at 1400 µg/mL and above without metabolic activation following 4 and 24 hours treatment, and at 2800 µg/mL and above with metabolic activa-tion (4 h treatment).
The test medium was checked for precipitation or phase separation at the end of each treatment period (4 or 24 hours) prior to removal of the test item. No precipitation or phase separation occurred up to the maximum concentration with and without metabolic activa-tion after 4 and 24 hours treatment.
There was no relevant shift of pH and osmolarity of the medium even at the maximum concentration of the test item.
Based on the results of the pre-experiment, the individual concentrations of the main experiments were selected. A series of concentrations spaced by a factor of 2 was placed into the lower range. Narrower spacing was used at high concentrations to cover the cytotoxic range more closely.
COMPARISON WITH HISTORICAL CONTROL DATA: Complies
ADDITIONAL INFORMATION ON CYTOTOXICITY: Cytotoxic effects, indicated by a relative cloning efficiency I of less than 50% compared to the corresponding solvent control in both parallel cultures, occurred in experiment I at 1400 µg/mL and above without and at 4200 µg/mL and above with metabolic activation. In experiment II cytotoxic effects were noted at 1400 µg/mL and above without and at 5600 µg/mL and above with metabolic activation. - Conclusions:
- Conclusion:
In conclusion it can be stated that under the experimental conditions reported the test item did not induce gene mutations at the HPRT locus in V79 cells. Therefore, Acid Brown 425 is considered to be non-mutagenic in this HPRT assay. - Executive summary:
The test item Acid Brown 425 was assessed for its potential to induce gene mutations at the HPRT locus using V79 cells of the Chinese hamster.
The study was performed in two independent experiments, using identical experimental procedures. In the first experiment the treatment period was 4 hours with and without metabolic activation. The second experiment was performed with a treatment time of 4 hours with and 24 hours without metabolic activation.
The cell cultures were evaluated at the following concentrations:
exposure
periodS9
mixconcentrations
in µg/mLExperiment I
4 hours
-
350
700
1400
2100
2800
4 hours
+
700
1400
2800
4200
5600
Experiment II
24 hours
-
175
350
700
1400
2100
4 hours
+
700
1400
2800
4200
5600
The maximum concentration in the experimental parts without metabolic activation was limited by cytotoxicity of the test item. Precipitation at the end of treatment, visible to the unaided eye, was not observed.
Cytotoxic effects, indicated by a relative cloning efficiency I of less than 50% compared to the corresponding solvent control in both parallel cultures, occurred in experiment I at 1400 µg/mL and above without and at 4200 µg/mL and above with metabolic activation. In experiment II cytotoxic effects were noted at 1400 µg/mL and above without and at 5600 µg/mL and above with metabolic activation.
No relevant and reproducible increase in mutant colony numbers/106cells was observed in the main experiments up to the maximum concentration. The threshold of three times the mutation frequency of the corresponding solvent control was reached in the first culture of the second experiment with metabolic activation at 5600 µg/mL. The range of the historical solvent control data (3.4 - 36.6 mutant colonies/106cells) was also exceeded at this concentration (61.0 mutant colonies/106cells). This isolated increase was judged as biologically irrelevant however, as the threshold was not reached in the parallel culture under identical experimental conditions and there was no dose dependent increase as indicated by the lacking statistical significance.
In the second experiment the mutation frequency slightly exceeded the historical range of solvent controls at 700 µg/mL in culture I with metabolic activation (41.9 mutant colonies/106cells). However, the induction factor did not exceed the threshold of three times the corresponding solvent control and statistical analysis showed that there was no dose dependent increase. Therefore, the increase was judged as biologically irrelevant.
A linear regression analysis (least squares) was performed to assess a possible dose dependent increase of the mutation frequency. No significant dose dependent trend of the mutation frequency indicated by a probability value of <0.05 was determined in any of the experimental groups.
In both experiments of this study (with and without S9 mix) the range of the solvent controls was from 16.8 up to 35.5 mutants per 106cells; the range of the groups treated with the test item was from 8.1 to 61.0 mutants per 106cells.
EMS(150 µg/mL) and DMBA (1.1 µg/mL) were used as positive controls and showed a distinct increase of induced mutant colonies.
Reference
Summary Table
relative | relative | relative | mutant | relative | relative | relative | mutant | |||||
conc. | S9 | cloning | cell | cloning | colonies/ | induction | cloning | cell | cloning | colonies/ | induction | |
µg/mL | mix | efficiency I | density | efficiency II | 106cells | factor | efficiency I | density | efficiency II | 106cells | factor | |
% | % | % | % | % | % | |||||||
Column | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |
Experiment I / 4 h treatment | culture I | culture II | ||||||||||
Solvent control with water | - | 100.0 | 100.0 | 100.0 | 19.2 | 1.0 | 100.0 | 100.0 | 100.0 | 16.8 | 1.0 | |
Positive control (EMS) | 150.0 | - | 89.0 | 89.8 | 142.9 | 61.7 | 3.2 | 86.3 | 80.5 | 107.3 | 65.3 | 3.9 |
Test item | 175.0 | - | 83.9 | culture was not continued# | 94.7 | culture was not continued# | ||||||
Test item | 350.0 | - | 80.4 | 81.3 | 74.6 | 21.8 | 1.1 | 94.6 | 79.2 | 63.2 | 27.9 | 1.7 |
Test item | 700.0 | - | 88.2 | 77.6 | 124.6 | 15.7 | 0.8 | 97.6 | 89.2 | 106.1 | 10.3 | 0.6 |
Test item | 1400.0 | - | 31.8 | 71.4 | 112.3 | 17.3 | 0.9 | 36.9 | 76.1 | 92.9 | 17.4 | 1.0 |
Test item | 2100.0 | - | 13.1 | 63.6 | 104.6 | 11.9 | 0.6 | 15.3 | 68.0 | 103.2 | 11.0 | 0.7 |
Test item | 2800.0 | - | 2.4 | 65.5 | 82.5 | 22.1 | 1.2 | 4.1 | 60.4 | 97.7 | 14.8 | 0.9 |
Solvent control with water | + | 100.0 | 100.0 | 100.0 | 28.3 | 1.0 | 100.0 | 100.0 | 100.0 | 25.1 | 1.0 | |
Positive control (DMBA) | 1.1 | + | 88.5 | 76.8 | 139.5 | 221.4 | 7.8 | 85.3 | 78.2 | 106.4 | 147.0 | 5.9 |
Test item | 350.0 | + | 107.8 | culture was not continued# | 96.8 | culture was not continued# | ||||||
Test item | 700.0 | + | 92.4 | 74.0 | 173.3 | 14.3 | 0.5 | 93.4 | 84.0 | 84.3 | 22.5 | 0.9 |
Test item | 1400.0 | + | 95.7 | 81.0 | 155.4 | 21.6 | 0.8 | 86.2 | 77.1 | 96.2 | 26.3 | 1.1 |
Test item | 2800.0 | + | 78.4 | 75.6 | 129.5 | 10.2 | 0.4 | 73.6 | 80.4 | 118.8 | 13.7 | 0.5 |
Test item | 4200.0 | + | 40.8 | 74.0 | 118.8 | 31.6 | 1.1 | 40.3 | 74.5 | 128.2 | 29.4 | 1.2 |
Test item | 5600.0 | + | 24.6 | 48.5 | 177.0 | 8.1 | 0.3 | 27.7 | 64.9 | 143.4 | 14.1 | 0.6 |
Experiment II / 24 h treatment | culture I | culture II | ||||||||||
Solvent control with water | - | 100.0 | 100.0 | 100.0 | 31.6 | 1.0 | 100.0 | 100.0 | 100.0 | 35.5 | 1.0 | |
Positive control (EMS) | 150.0 | - | 77.5 | 170.7 | 97.3 | 491.8 | 15.6 | 92.1 | 108.0 | 93.9 | 521.9 | 14.7 |
Test item | 87.5 | - | 99.5 | culture was not continued# | 106.4 | culture was not continued# | ||||||
Test item | 175.0 | - | 113.1 | 116.2 | 94.2 | 16.5 | 0.5 | 100.3 | 105.5 | 93.1 | 26.4 | 0.7 |
Test item | 350.0 | - | 85.9 | 74.3 | 99.5 | 36.7 | 1.2 | 87.7 | 84.7 | 106.1 | 35.2 | 1.0 |
Test item | 700.0 | - | 80.0 | 124.2 | 98.6 | 11.9 | 0.4 | 77.5 | 75.7 | 75.6 | 40.6 | 1.1 |
Test item | 1400.0 | - | 36.9 | 84.7 | 104.1 | 19.2 | 0.6 | 26.1 | 68.0 | 107.1 | 21.0 | 0.6 |
Test item | 2100.0 | - | 1.3 | 93.4 | 108.2 | 8.6 | 0.3 | 0.9 | 41.7 | 120.4 | 23.8 | 0.7 |
Experiment II / 4 h treatment | ||||||||||||
Solvent control with water | + | 100.0 | 100.0 | 100.0 | 20.5 | 1.0 | 100.0 | 100.0 | 100.0 | 24.4 | 1.0 | |
Positive control (DMBA) | 1.1 | + | 76.7 | 68.7 | 51.7 | 1105.4 | 54.0 | 90.6 | 81.7 | 76.5 | 911.6 | 37.3 |
Test item | 350.0 | + | 96.4 | culture was not continued# | 102.4 | culture was not continued# | ||||||
Test item | 700.0 | + | 83.6 | 85.0 | 78.5 | 41.9 | 2.0 | 89.7 | 87.3 | 83.8 | 20.4 | 0.8 |
Test item | 1400.0 | + | 76.0 | 98.7 | 95.0 | 23.8 | 1.2 | 85.7 | 72.2 | 113.7 | 16.4 | 0.7 |
Test item | 2800.0 | + | 61.8 | 71.7 | 97.6 | 23.0 | 1.1 | 64.6 | 75.5 | 104.5 | 9.8 | 0.4 |
Test item | 4200.0 | + | 59.8 | 61.1 | 72.7 | 26.6 | 1.3 | 51.9 | 56.1 | 101.6 | 27.2 | 1.1 |
Test item | 5600.0 | + | 30.8 | 46.1 | 63.2 | 61.0 | 3.0 | 27.9 | 62.9 | 101.9 | 38.9 | 1.6 |
# culture was not continued as a minimum of only four analysable concentrations is required
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
The hazard of gene mutation was determined in mammalian cells (V79) in vitro with the following result: not mutagenic. The study included several repeats with and without metabolic activation.
The test item did not induce gene mutations in 2 standard Ames tests in salmonella typhimurium or escherichia coli. An analogous substance did not induce gene mutations in Salmonella typhimurium with and without metabolic activation by syrian hamster liver S9-mix.
Chromosomal aberrations were determined after in vitro incubation of human lymphocytes. No hazard was identified.
In conclusion the test item is considered not mutagenic in in-vitro test systems.
Justification for selection of genetic toxicity endpoint
Mammalian cells are considered the most relevant available model for gene mutation in humans.
Justification for classification or non-classification
No classification.
The test item did not induce gene mutations in bacteria and mammalian cells and did not provoke chromosomal aberrations in human lymphocytes.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
